Altimmune (ALT) Statistics

Altimmune Inc (ALT) is a biopharmaceutical company focused on developing and commercializing immunotherapeutic products. With a market capitalization of $X, Altimmune has become a significant player in the healthcare sector. The company's valuation metrics including price to earnings ratio (P/E), price to sales ratio (P/S), and price to book ratio (P/B) reflect its potential for growth and profitability. ALT's current P/E ratio is XXXX, which indicates that investors are willing to pay more for each dollar of earnings. The P/S ratio of ALT is XXXX, suggesting that the market values the company's sales at a premium. ALT's P/B ratio is XXXX, indicating that the stock is trading at a higher price compared to its book value.

When analyzing the fundamentals of Altimmune Inc (ALT), it is important to consider factors such as revenue per share, enterprise to EBITDA, profit margin, total debt, and gross profit. The revenue per share of ALT is XXXX, demonstrating the company's ability to generate revenue on a per share basis. ALT's enterprise to EBITDA ratio is XXXX, indicating its financial efficiency and profitability. The profit margin of ALT is XXXX, indicating the percentage of each dollar of revenue that the company retains as profit. ALT's total debt is XXXX, representing the amount of money the company owes to creditors. Lastly, ALT's gross profit is XXXX, reflecting the company's profitability after deducting the cost of goods sold.